This 1 hour, interactive, online CME/CMLE module will help pathologists, laboratory professionals, and other members of the cancer care team gain deeper scientific knowledge in immuno-oncology (IO) and keep up with the rapidly evolving science of IO biomarkers. In this module, participants will learn about evolving concepts in IO biomarker testing, including the role of tumor mutational burden (TMB). Additionally, the latest information on PD-L1 testing and interpretation for different cancers will be addressed, as well as the expanding use of checkpoint inhibitors for treatment.
- Discuss the current and evolving role of I-O biomarkers such as PD-L1 and TMB
- Identify the advantages and limitations of current I-O biomarker testing and interpretation methods
- Describe the science of TMB and its potential role as a predictive I-O biomarker
- Summarize ongoing investigational efforts to utilize biomarkers and better predict response to immune checkpoint inhibitor (CPI) therapy
- Outline the expanding use of immune CPIs to treat different types of cancers
Robert A. Anders, MD, PhD
Associate Professor, Pathology
Johns Hopkins University
Gastrointestinal and Liver Pathologist
Johns Hopkins Hospital
Feriyl Bhaijee, MD
Staff Pathologist, Anatomic Pathology
The American Society for Clinical Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The ASCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
These activities also meet CC Part II Lifelong Learning and Self-Assessment Module (SAMs CME) requirements.
ASCP designates these enduring materials for a maximum of 1.0 CMLE credit. These activities meet CMP and state re-licensure requirements for laboratory personnel.
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, option 2, in the US & Canada or internationally at access code + 3-1-312-541-4848. Monday-Friday, 8:30am - 5pm Eastern Time.
Method of Participation
To complete the activity and receive credit, the participant must complete the online course. CME certificates will be provided on-line.
Funded by an independent educational grants from Bristol-Myers Squibb.